Adiposs’ CHF 1.8 Million Pre-Series A Round

MLL advised Clinical Research Ventures (CR Ventures).Adiposs, the developer of a unique diagnostic product for the non-invasive early detection of body wasting cachexia, announced a CHF…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here